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Abstract
Cu and Zn have naturally occurring non radioactive isotopes, and their isotopic systematics in a
biological context are poorly understood. In this study we used double focussing mass
spectroscopy to determine the ratios for these isotopes for the first time in mouse brain. The Cu
and Zn isotope ratios for four strains of wild-type mice showed no significant difference (δ65Cu -
0.12 to -0.78 permil; δ66Zn -0.23 to -0.48 permil). We also looked at how altering the expression
of a single copper binding protein, the prion protein (PrP), alters the isotope ratios. Both knockout
and overexpression of PrP had no significant effect on the ratio of Cu isotopes. Mice brains
expressing mutant PrP lacking the known metal binding domain have δ65Cu isotope values of on
average 0.57 permil higher than wild-type mouse brains. This implies that loss of the copper binding
domain of PrP increases the level of 65Cu in the brain. δ66Zn isotope values of the transgenic mouse
brains are enriched for 66Zn to the wild-type mouse brains. Here we show for the first time that
the expression of a single protein can alter the partitioning of metal isotopes in mouse brains. The
results imply that the expression of the prion protein can alter cellular Cu isotope content.
Background
Copper (Cu) and zinc (Zn) have essential roles in mam-
malian metabolism: copper in the formation of haemo-
globin and red blood cells and Zn and Cu in several
enzymes in a number of metabolic pathways. A number
of neurodegenerative diseases are associated with abnor-
malities in the tissue distribution of these trace metals,
such as Cu in prion disease [1,2], and Cu and Zn in Alzhe-
imer's disease [3]. Cu has the two isotopes 65Cu and 63Cu,
Zn has the five isotopes 64Zn, 66Zn, 67Zn, 68Zn and 70Zn.
Different isotopes of the same element have different
masses, which leads to different behaviour, and this con-
tribution is concerned with the extent these isotopes are
fractionated by small changes in a complex biological sys-
tem, the brain.
Precise analyses of the ratios of transition stable isotopes
has only been possible since the development of multi-
collector inductively coupled plasma mass spectrometers
and associated extraction techniques [4-7]. Variations in
the isotopic composition are expressed by delta notation
[δ66Zn = (66Zn/64Znsample/66Zn/64Znstandard -1)*1000, and
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which is the deviation of a sample from an international
standard in permil (1‰ = 0.1%). Variations in the iso-
topic composition of trace metals within organisms result
from two effects. Biogeochemical processes in the envi-
ronment lead to different isotopic compositions in, for
example, soil, water, and plants. Isotope ratios may there-
fore be used to trace the origin, or source, of the element
in question at the time it enters the body. Secondly, heavy
stable isotope ratios fractionate during biochemical proc-
esses in organisms, and they are known to fractionate
both during the uptake of trace metals into a cell, and as
metals pass through membranes within the cell [8,9]. A
study of Fe isotopes in human blood samples established
that they were fractionated, and that the mean Fe isotope
value is different in the blood of men and of women [10].
Such isotope fractionations reflect the fact that the isotope
with a lower number of neutrons is kinetically more active
and therefore used preferentially in biochemical proc-
esses.
This study focuses on the extent that small changes in a
complex system affect trace metal Cu and Zn isotope
ratios. If they do change such isotopes may be used as a
new medical tool to investigate the pathways and parti-
tioning of trace metals in human beings. Cu and Zn con-
centrations are routinely measured to determine their
distribution in the brain, and the involvement of these
elements in, for example, protein or enzyme function has
been studied in detail [11,12]. Both metals are distributed
throughout the brain with zinc concentrations being
approximately twice that of copper (Cu being approxi-
mately 5 parts per million). Both metals are associated
with large number of proteins and are important co-fac-
tors in the activity of many enzymes. Currently, no suita-
ble method exists to examine pathways by which
naturally occurring isotopes of metals are transported and
partitioned within the animal body or whether they could
be used to provide markers of abnormal transport and
partitioning of trace metals in disease. Thus the question
is the extent to which the isotope ratios of a metal are
influenced by the expression of one particular protein in a
biological system. Mice brains were analysed due to the
availability of a suitable range of transgenically manipu-
lated mice, allowing examination of the effects of altera-
tions to a single proteins on the isotope ratios in a
complex system like the brain.
The protein we chose to study was the prion protein, as it
is a Cu-binding glycoprotein that can bind up to four Cu
atoms, it is concentrated at synapses and may protect
them from oxidative stress [13]. The metal ions (usually
Cu) bind to a specific domain in the protein called the
octameric repeat region. Deletion of this region from the
protein abolishes metal binding to the protein [14].
Together with Cu the protein forms a complex that pos-
sesses anti-oxidant activity, and that may have important
implications for synaptic homeostasis [13]. Prion protein
misfolding is associated with the development of animal
or human prion diseases (Scrapie, Bovine spongiform
encephaloathy, Creutzfeldt-Jacob disease). Other trace
metals such as Zn and Mn can substitute for Cu at the
binding site [14]. However, while the affinity for Cu is
high, that for Zn is very low. It is now well established that
the prion protein (PrP) has an influence on cellular cop-
per metabolism. As an example exposure of cells to high
Cu concentrations increase PrP expression [15] and
caused PrP to internalise [16], delivering copper into the
cell [17]. Because PrP has a low zinc affinity it would be
out competed by other zinc binding proteins and is
unlikely to play any role in zinc metabolism.
This study presents for the first time accurate measure-
ments of the ratio copper and zinc isotopes as they occur
naturally in the brain. By studying these ratios in the
brains of transgenic mice we sought to establish whether
altered expression of a single protein can alter these iso-
topic ratios. We have shown that altered expression of the
prion protein, in the normal cellular, non-aggregating
isform, can selectively modify Cu isotope ratios. This
implies that Cu isotopes are sensitive to the presence of
different Cu-binding sites in the brain.
Methods
Mouse brains
The brains of different mouse strains were collected from
adult (4 month old mice) or newborn mice. Mice studied
included four lines of wild-type mice which included:
MF1, 129Sv, FvB and C57BL/6 (Harlan). Also studied was
a transgenic line included as a control for transgenic
effects known as Harry [18] and three lines of mice in
which the prion protein had been modified. The prion
protein transgenic mice included prion protein knockout
mice (PrPo/o)[19], mice overexpressing the protein (Tg20)
[20] and mice which express a version of the prion protein
lacking the octameric repeat region on a prion protein
knockout background (C4) [21]. The comparable control
mouse for the prion transgenic mice was the 129Sv mice.
Isotope analyses
A method to separate Cu, Fe and Zn from silicate samples
using a strongly basic anion resin has been described in
detail by Marechal et al. (1999) [6]. This protocol, using
AG MP-1 resin (Bio-Rad, CA, USA) was adopted here to
accommodate smaller sample sizes and to decrease the
size of the environmental blank contribution. It follows
the approach of Archer and Vance [7] who provide more
details of the analytical technique. The samples were
digested using concentrated HNO3 + H2O2 and concen-
trated HCl in a second step. Following sample digestionPage 2 of 7
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H2O2. The majority of matrix elements were removed by
addition of a further 2 ml of 7 M HCl + H2O2, before col-
lecting Cu in 8 ml 7 M HCl + H2O2; Fe was eluted by pass-
ing 4.5 ml 2 M HCl + H2O2 before finally collecting Zn in
4 ml 0.5 M HNO3 [7].
All analyses were performed on a ThermoFinnigan Nep-
tune double focussing mass spectrometer at the University
of Bristol (see [7] for a detailed description). Purified ana-
lyte fractions were introduced into the mass spectrometer
in 2% HNO3 by means of a CETAC (Omaha, NE, USA)
Aridus desolvating spray chamber fitted with a CPI
(Amsterdam, Neth.) PFA nebuliser and spray chamber to
give enhanced sensitivity. Instrumental mass fractiona-
tion was corrected for using external normalisation tech-
niques described by Marechal et al. [6], with careful
attention being paid to matrix matching of samples and
standards (cf. Archer and Vance [7]). We used the Cu
standard from NIST and the Zn standard from Lyons JMC,
and 60Ni was monitored to correct for the isobaric inter-
ference of 64Ni on 64Zn.
Statistical analysis of the data was carried out using "Anal-
ysis of Variance" (ANOVA) or with a two tailed Student's
t-test.
Results and discussion
Cu and Zn isotopes were analysed by MC-ICP-MS and the
results are presented in Table 1. The internal reproducibil-
ity for measurement of Cu and Zn isotopes was 0.03‰ (2
sigma). The external reproducibility for Cu and Zn by
sample bracketing was 0.08‰ (2 sigma) and for Zn with
a double spike 0.04‰ (2 sigma). All the observed shifts
in isotopic ratios lie on the mass fractionation line (Fig.
1), and thus they all obey the mass fractionation law.
In order to eliminate age or diet effects, only mice held
under controlled conditions were chosen. The mice were
4 months old and they had all been fed with the same
mouse pellets. Cu and Zn isotopes were analysed in 'nor-
mal' wild type mouse brains from 4 different strains with
no genetic modifications (n = 19), in prion protein over-
expressed mouse brains (TG20, for details see [20]) (n =
6), in brains in which the prion protein had been deleted
(PrPo/o, for details see [19]) (n = 4), in brains in which the
copper-binding region of the prion protein had been
knocked out (C4, for details see [21]) (n = 4) and in other
transgenic mice from the line Harry which carry a luci-
ferase transgene driven by promoter/enhancer elements
from the Igf2/H19 locus (for details see [18]) (n = 4). Four
new born mice brains in which the prion protein had
been deleted were also analysed to assess the influence of
age on the Cu and Zn isotopic composition. In all cases
whole brains were dissolved in concentrated nitric and
hydrochloric acid for analysis.
The δ65Cu values in the wild type mice brains of four dif-
ferent strains (MF1, 129, C57 BL/6 and FvB) varied
between -0.12 and -0.78 permil, and δ66Zn between -0.23
and -0.48 permil (the results are plotted on a diagram of
δ65Cu against δ66Zn in Figure 2). The range of Cu and Zn
isotopic ratios in the wild-type mice brains is not under-
stood, but there was no significant difference between the
isotope ratios of the different wild type mice strains. In
more detail the two sample t-test, indicates that for most
of the samples the wild-type mice brains show no signifi-
cant differences to each other (e.g. 129 – C57: δ65Cu: t =
0.09, df = 7, p = 0.92, δ66Zn: t = 1.47, df = 7, p = 0.18;
δ67Zn: t = 0.25, df = 7, p = 0.80). This implies that the dif-
ferent genetic backgrounds had no significant influence
on the isotopic ratios. These results present the first assess-
ment of Cu and Zn isotope ratios in the brain.
There has been one other study on the fractionation of Cu
and Zn isotopes in biological tissue. Cu uptake in vitro
into the apoprotein of azurin expressed in Escherichia coli
fractionates the Cu isotopes, and the azurin (δ65Cu -1.64)
was enriched in the lighter isotope relative to the source
material (δ65Cu -0.11) [9]. In an in vivo experiment,
where the intact Cu protein azurin was synthesised
directly inside cells of the bacterium Pseudomonas aeru-
ginosa, the Cu isotope composition of the azurin (δ65Cu -
1.09) was also enriched in the lighter isotope [9]. It
appears that the Cu isotopic ratios of the mouse brains lie
within the range of other biological samples.
In order to determine if any form of genetic manipulation
could alter isotope ratios a transgenic line was chosen at
random and the isotope ratios in the brain compared to
that for the brains of the matching mouse strain from
which they were derived (C57BL/6). The δ65Cu and δ66Zn
values of the wild type mice brains overlap with those
from transgenic mouse brains from the line Harry in
which the genetic changes have no connection with Cu or
Zn (Fig. 2). These results show that transgenic manipula-
tion on its own did not change the Cu or Zn isotopic com-
position significantly.
We then studied a series of different transgenic mice in
which transgenic manipulation of a single protein is
known to alter the copper content of the brain. The prion
protein in these mice was either either overexpressed
(Tg20) deleted (PrPo/o) or modified to lack the main
metal binding domain (C4). All three groups plot in dif-
ferent fields to the wild type and line Harry mice brains on
the plot of Cu versus Zn isotopes (Fig. 2). Specifically the
prion protein overexpressed (Tg20) deleted (PrPo/o) or
modified to lack the main metal binding domain (C4)Page 3 of 7
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Table 1: Cu and Zn isotopic compositions of the mouse brains
delta65Cu/63Cu delta66Zn/64Zn delta67Zn/64Zn
MF1 -0.59 -0.27 -0.47
-0.35 -0.30 -0.46
-0.33 -0.35 -0.54
-0.49 -0.29 -0.47
-0.43 -0.23 -0.30
-0.47 -0.29 -0.44
129 -0.29 -0.25 -0.47
-0.23 -0.42 -0.69
-0.78 -0.37 -0.56
-0.77 -0.32 -0.52
Fvb -0.12 -0.37 -0.53
-0.16 -0.39 -0.52
-0.38 -0.32 -0.44
-0.3 -0.36 -0.51
C57 -0.35 -0.31 -0.46
-0.46 -0.41 -0.57
-0.7 -0.43 -0.59
-0.73 -0.48 -0.65
-0.42 -0.40 -0.60
PrP-KO (adult) -0.56 -0.20 -0.26
-0.16 -0.19 -0.23
-0.14 -0.11 -0.13
-0.16 -0.02 -0.04
PrP-KO (newborn) -0.33 -0.23 -0.30
-0.17 -0.19 -0.18
-0.1 0.00 0.07
-0.38 -0.10 -0.15
C4 -0.02 -0.15 -0.14
0.31 -0.22 -0.29
0.04 -0.21 -0.26
-0.09 -0.03 -0.06
TG20 0.18 0.08 0.12
-0.36 -0.04 -0.05
0.26 -0.09 -0.13
-0.44 -0.12 -0.17
-0.37 -0.25 -0.34
-0.58 -0.21 -0.28
Line Harry -0.14 -0.26 -0.32
-0.17 -0.36 -0.46
-0.21 -0.25 -0.29
-0.46 -0.36 -0.5
The Cu and Zn isotope ratios of mice brains, expressed in the delta notation (as discussed in the text. The different samples are: MF1, 129, FvB and 
C57 BL/6 – wild-type mouse brains; PrP-KO (adult) prion protein deleted mouse brains, adult; PrP-KO (newborn) prion protein deleted mouse 
brains, new born; C4 – Cu binding domain of the prion protein deleted; TG20 – prion protein overexpressed; Line Harry – transgenic mouse brains 
with the genetic changes have no connection with Cu or Zn.
Geochemical Transactions 2008, 9:11 http://www.geochemicaltransactions.com/content/9/1/11brains all have more positive Zn isotope ratios than the
wild type and line Harry mice brains (δ66Zn: R2 = 0.70, p
< 0.001; δ67Zn: R2 = 0.76, p < 0.001). In contrast, only the
C4 samples, those without the Cu binding domain of the
prion protein, have consistently more positive Cu isotope
ratios (Fig. 2), as do two samples from TG20. The average
δ65Cu value of the C4 brains is 0.57 permil enriched in the
heavy Cu isotope (65Cu) compared to the wild type mice
brains, and this difference was highly significant
(ANOVA, R2 = 0.45, p = 0.01). Analysis was also carried
out for these results with the Student's t-test. The analyses
confirm the inferences from the figures, namely, that 129
– C4 are significantly different (δ65Cu: t = -3.339, df = 6, p
= 0.02; δ66Zn: t = -3.269, df = 5, p = 0.02; δ67Zn: t = -5.004,
df = 5, p = 0.01) and that 129 – PrPo/o show no significant
differences for the Cu isotope ratios (δ65Cu: t = -1.454, df
= 6, p = 0.19), but are different for the Zn isotope ratios
(δ66Zn: t = -3.792, df = 6, p = 0.01; δ67Zn: t = -5.746, df =
6, p = 0.001)).
Finally, we tested whether changes in isotopes could be
something that occurs with increased age. We examined
the metal isotope ratios in new born mice and compared
them to those from the adults in this study. The one-day
old mice brains with the prion protein deleted (δ65Cu
ranges between -0.10 and -0.38, and δ66Zn between 0.00
and -0.23 permil) fell within the field of the older mice
brains in which the prion protein had been deleted (δ65Cu
ranges between -0.14 and -0.56 permil, and δ66Zn
between -0.02 and -0.20 permil, Table 1). Comparison
between PrPo/o-adult and PrPo/o-young using the Stu-
dent's t-test confirm that these two groups show no signif-
icant differences from each other (δ65Cu: t = -0.082, d = 6,
p = 0.98; δ66Zn: t = 0.00, df = 6, p = 1.00; δ67Zn: t = -0.272,
df = 6, p = 0.80). This strongly suggests that changes with
age did not result in analytically significant differences in
Cu and Zn isotopic ratios, at least in the first 4 months.
Neither overexpression nor the lack of expression of PrP
alters the partition of the Cu isotopes. However, expres-
sion of a form of PrP that cannot bind Cu results in
increased levels of the heavier Cu isotope. The implication
is that the presence of PrP inhibits mechanisms that
would otherwise regulate the Cu content to maintain the
normal Cu isotope ratio. When PrP can bind Cu these
alternative mechanisms are not required. When PrP is not
A plot of δ66Zn versus δ67Zn for all the brains analysed (Table 1) showing that the obse ved shifts in isotopic ratios lie on the mass fractionation line), and thus they ll obey the mass fractionat on lawFigure 1
A plot of δ66Zn versus δ67Zn for all the brains ana-
lysed (Table 1) showing that the observed shifts in 
isotopic ratios lie on the mass fractionation line), and 
thus they all obey the mass fractionation law. Open 
triangles – wild mouse strains; filled triangles – prion protein 
depleted; open circles – TG20; grey squares – C4; grey dia-
monds – line Harry.
A plot of δ65Cu and δ66Zn for all the mice brains analysedFigure 2
A plot of δ65Cu and δ66Zn for all the mice brains ana-
lysed. The wild-type mouse brains are from four different 
strains, including MF1 (n = 6), 129 SV (n = 4), C57BL6 (n = 
5), FVB (n = 4), and the transgenic mouse brains are from the 
line Harry (n = 4) in which the genetic changes have no con-
nection with Cu or Zn. The C4 transgenic mouse brains have 
the Cu binding domain of the prion protein deleted (C4, n = 
4), PrP have the prion protein deleted (n = 4) and TG20 have 
the prion protein overexpressed (n = 6).Page 5 of 7
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able to compensate for the loss of expression. At present,
if these alternative balancing mechanisms exist, they
remain unknown. Tg20 mice express 10 time the normal
level of PrP with little measurable variation in the level of
the protein times the normal levels of PrP [20]. However,
previous studies have shown the amount of Cu bond per
molecule of PrP in Tg20 mice was greatly reduced when
compared to wild-type [22]. This implies that the impact
of increased expression of PrP on Cu isotopes is limited by
the availability of Cu to bind to it. However, it is impor-
tant to note the huge variation in the values for the TG20
mice. This variation is greater than between different wild-
type mouse lines and suggests that overexpression of PrP
causes disturbance to maintenance of isotope ratios at an
individual level. This would imply that expression of PrP
is not the prime mechanism by which a cell maintains the
ratio balance.
A very interesting observation is that wild-type mice show
little variation in the ratios of the three Zn isotopes (Fig.
1). This again implies tight regulation of Zn isotope con-
tent of the brain. However, any form of manipulation of
PrP resulted in a significant change to the ratios. It is pos-
sible that either loss or overexpression of a copper binding
protein could have a similar effect on the way a cell proc-
esses Zn. In the case of deleting PrP it is possible that com-
pensatory mechanisms, increasing Cu uptake or
utilisation could be non selective and also alter Zn uptake.
In the case of overexpression of PrP, PrP itself could alter
internalisation of Zn either by directly binding Zn as has
been suggested [14] or indirectly increasing transport of
Zn. In the latter case other non selective transport proteins
such as divalent metal transporter (DMT-1) could show
an increase transport of Zn due to decreased availability of
Cu (due to it being bound to PrP). Again, the mice over-
expressing PrP showed high variability in Zn isotopic
ratios in the brain. This variation was similar to that seen
for Cu ratios. Although there is no information concern-
ing the mechanism, it does suggest that there is some form
of co-regulation of this process maintaining isotope ratios
for different metals. At the level of individuals the greater
variation in values implies an increased complexity of the
alternative routes for metal entry into cells.
In terms of the relationship of Zn isotopes ratios to PrP,
the simples explanation of the results is that they are unre-
lated to the metal binding capacity of PrP. While changes
in Cu isotopes can clearly be related to the loss of metal
binding to the protein, the change in Zn isotopes is only
consistent with a genetic modification of the mice involv-
ing the PrP gene. This might suggest that Zn isotope ratios
are more sensitive to the modification of cellular metabo-
lism that Cu isotope ratios. This means that the study of
Cu isotope ratios is more likely to uncover mechanisms
that could be utilised to understand how a protein alters
copper metabolism than the study of Zn isotope ratios.
This possibly relates to the different nature of the two met-
als and the greater role of Cu in reactions that can cause
damage to cells through oxidative stress.
Conclusion
This study establishes for the first time that a minor
change to a biological system can alter the distribution of
metal isotopes in ways that could not be predicted. Until
this study it has not been possible to establish the wild-
type ratios of Cu and Zn isotopes. The observed differ-
ences in the Cu and Zn isotope composition of mouse
brains with different protein expression profiles supports
the hypothesis that trace metal isotopes can be used to
examine processes leading to brain damage and disease
and pathways by which metals are transported through
the animal body. As the altered ratios were not observed
in the Harry transgenic mouse line it is clear that these
changes are specific for relevant metal binding proteins.
These observations may open up a new field of medical
research using geochemical tools. Other applications may
include other neurodegenerative diseases that are related
to trace metals like Alzheimer's disease [3,23,24] or Par-
kinson's disease [25]. However, further studies of the
basic mechanisms involved are essential before such
information could have any meaning in a diagnostic
sense. Nevertheless, these findings highlight that an essen-
tial unexplored aspect of metalochemistry has a signifi-
cant biological relevance. How different metal isotopes
are utilised biologically remains unknown but our data
provides evidence that they are used differently. If cells in
the brain selectively regulate the isotopes that enter the
brain, then differential utilisation of these isotopes by the
brain might lead to important consequences for impor-
tant cellular processes. The consequences of altering this
differential utilisation might have a significant impact on
health issues.
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